International Stem Cell (ISCO) Other Non Operating Income (2010 - 2026)
International Stem Cell (ISCO) posted quarterly Other Non Operating Income of -$1000.0 for Q4 2024, down 120.0% quarter-over-quarter from $5000.0 in Q2 2024.
International Stem Cell (ISCO) Other Non Operating Income (2010 - 2026) Analysis & Trends
International Stem Cell (ISCO) has reported Other Non Operating Income for 7 consecutive years, with -$1000.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Other Non Operating Income changed N/A year-over-year to -$1000.0; the TTM figure through Dec 2024 stood at $4000.0 (up 33.33% YoY), while the FY2024 annual figure was $4000.0, down 50.0% from the prior year.
- Other Non Operating Income slipped to -$1000.0 in Q4 2024 per ISCO's latest filing, from $5000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $1.1 million in Q4 2021 and bottomed at -$8000.0 in Q3 2022.
- Historically, Other Non Operating Income has averaged $282875.0 across 4 years, with a median of $6500.0 in 2023.
- Annual changes were most pronounced in 2022 — Other Non Operating Income plunged 101.68% — and 2024, when it slumped 37.5%.
- International Stem Cell's Other Non Operating Income stood at $1.1 million in 2021, then tumbled by 100.44% to -$5000.0 in 2022, then surged by 260.0% to $8000.0 in 2023, then sank by 112.5% to -$1000.0 in 2024.
- Business Quant data shows ISCO's Other Non Operating Income at -$1000.0 in Q4 2024, $5000.0 in Q2 2024, and $8000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | International Stem Cell | 3.76 Mn | 2.67 Mn | 1.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Jun 30, 2023 | 8,000.00 |
| Dec 31, 2022 | -5,000.00 |
| Sep 30, 2022 | -8,000.00 |
| Dec 31, 2021 | 1.13 Mn |
| Sep 30, 2021 | 476,000.00 |
| Jun 30, 2021 | 661,000.00 |
| Jun 30, 2019 | 2,000.00 |
| Dec 31, 2018 | -1,000.00 |
| Sep 30, 2018 | 43,000.00 |
| Jun 30, 2018 | 1,000.00 |
| Mar 31, 2018 | 2,000.00 |
| Sep 30, 2010 | 1,124.00 |
| Jun 30, 2010 | 350.00 |